Deregulation of P4HA2 has been implicated in various pathological disorders associated with increased fibrosis [7–10] and many solid tumors such as hepatocellular carcinoma, breast cancer, papillary thyroid cancer, and oral cavity squamous cell carcinoma [11–13]. This evidence concerns the gene P4HA2 and breast carcinoma.